Opsens Inc
TSX:OPS
Opsens Inc
TSX:OPS
Price:
2.9
CAD
Market Closed
Market Cap:
CA$329.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Opsens Inc
TSX:OPS
|
CA |
|
Nexen Tire Corp
KRX:002350
|
KR |
|
Magna International Inc
TSX:MG
|
CA |
|
S
|
San Miguel Corp
OTC:SMGBF
|
PH |
|
OrganiGram Holdings Inc
TSX:OGI
|
CA |
|
L
|
Learnd SE
XETRA:LRND
|
LU |
|
XORTX Therapeutics Inc
XTSX:XRTX
|
CA |
|
Fission Uranium Corp
TSX:FCU
|
CA |
Relative Value
There is not enough data to reliably calculate the relative value of OPS.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
OPS
Relative Value
Base Case
Not Available
Multiples Across Competitors
OPS Competitors Multiples
Opsens Inc Competitors
Opsens Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Opsens Inc
TSX:OPS
|
334.8m CAD | 6.9 | -27 | -31.2 | -26 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182B USD | 4.1 | 27.9 | 16 | 22 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.9B USD | 16.6 | 58.4 | 44.3 | 54.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.7B USD | 5 | 38.6 | 19.8 | 23.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.8B USD | 3.2 | 24.5 | 13.5 | 19.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.5B USD | 5.2 | 35.7 | 21 | 28.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.4B EUR | 1.8 | 19.7 | 11.1 | 15.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48B USD | 7.9 | 44.8 | 24.6 | 27 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.9B USD | 10.7 | 43.3 | 30.7 | 34 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.1B USD | 2.1 | 25.7 | 10.1 | 17.1 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33B USD | 6.1 | 22.2 | 15.6 | 17.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
